Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Gomez

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Obesity Surgery|May 9, 2025
Comparison of Home Sleep Polygraphy or Laboratory Polysomnography for the Diagnosis of OSA Before Bariatric SurgeryLuc Groshaeny, Emmanuel Gomez, Simon Valentin, et al.
European Journal of Internal Medicine|December 26, 2021
Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-upPaul Decker, Vincent Sobanski, Thomas Moulinet, et al.
The European Respiratory Journal|May 17, 2014
Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertensionAri Chaouat, Olivier Sitbon, Magalie Mercy, et al.
The European Respiratory Journal|April 20, 2021
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugsSimon Valentin, Arnaud Maurac, Olivier Sitbon, et al.
Respiratory Research|April 27, 2018
Rituximab for auto-immune alveolar proteinosis, a real life cohort studyBerenice Soyez, Raphael Borie, Cedric Menard, et al.
Respiratory Research|April 10, 2024
Phenotypes and outcome of diffuse pulmonary non-amyloid light chain deposition diseaseFrançois Lestelle, Catherine Beigelman, David Rotzinger, et al.
ERJ Open Research|December 3, 2024
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort studyYoann Guirriec, David Luque-Paz, Gontran Bernard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
Thorax|September 27, 2023
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohortAxelle Mabo, Raphael Borie, Lidwine Wemeau-Stervinou, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Obesity Surgery|May 9, 2025
Comparison of Home Sleep Polygraphy or Laboratory Polysomnography for the Diagnosis of OSA Before Bariatric SurgeryLuc Groshaeny, Emmanuel Gomez, Simon Valentin, et al.
European Journal of Internal Medicine|December 26, 2021
Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-upPaul Decker, Vincent Sobanski, Thomas Moulinet, et al.
The European Respiratory Journal|May 17, 2014
Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertensionAri Chaouat, Olivier Sitbon, Magalie Mercy, et al.
The European Respiratory Journal|April 20, 2021
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugsSimon Valentin, Arnaud Maurac, Olivier Sitbon, et al.
Respiratory Research|April 27, 2018
Rituximab for auto-immune alveolar proteinosis, a real life cohort studyBerenice Soyez, Raphael Borie, Cedric Menard, et al.
Respiratory Research|April 10, 2024
Phenotypes and outcome of diffuse pulmonary non-amyloid light chain deposition diseaseFrançois Lestelle, Catherine Beigelman, David Rotzinger, et al.
ERJ Open Research|December 3, 2024
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort studyYoann Guirriec, David Luque-Paz, Gontran Bernard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
Thorax|September 27, 2023
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohortAxelle Mabo, Raphael Borie, Lidwine Wemeau-Stervinou, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
Pageof 4